Guided Therapeutics Inc Share Price OTC Bulletin Board
Equities
US40171F3038
Advanced Medical Equipment & Technology
Sales 2022 | 13K 1.08M | Sales 2023 | 98K 8.18M | Capitalization | 8.31M 693M |
---|---|---|---|---|---|
Net income 2022 | -4M -334M | Net income 2023 | -3M -250M | EV / Sales 2022 | 1,118 x |
Net cash position 2022 | 50K 4.17M | Net Debt 2023 | 1.47M 122M | EV / Sales 2023 | 99.7 x |
P/E ratio 2022 |
-1.96
x | P/E ratio 2023 |
-2.09
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 56.2% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Faupel
CEO | Chief Executive Officer | 68 | 27/92/27 |
Founder | 68 | 27/92/27 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Imhoff
BRD | Director/Board Member | 74 | 10/06/10 |
Richard Blumberg
BRD | Director/Board Member | 67 | 10/16/10 |
Mark Faupel
CEO | Chief Executive Officer | 68 | 27/92/27 |
1st Jan change | Capi. | |
---|---|---|
+7.92% | 219B | |
+7.25% | 183B | |
+14.96% | 136B | |
+26.52% | 107B | |
-1.14% | 63.07B | |
+7.23% | 52.55B | |
+12.39% | 51.28B | |
+1.51% | 41.21B | |
+5.32% | 36.43B |